Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

15.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Selectins01:25

Selectins

4.8K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.8K
Antifungal Agents01:15

Antifungal Agents

89
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
89
Antibiotic Selection00:57

Antibiotic Selection

62.2K
Overview
62.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antrodia cinnamomea extract exhibits anti-melanogenic and anti-photoaging effects: potential for cosmetic and dermatological applications.

Scientific reports·2026
Same author

BMP4-driven morphogenetic reprogramming sustains EGFR-TKI resistance via SOX2 suppression and EMT activation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Corrigendum to "Bioabsorbable magnesium-based bulk metallic glass composite (BMGC) for improved medial opening wedge high tibial osteotomy in knee osteoarthritis" [J Orthop Transl <b>50</b>, January 2025, Pages 97-110].

Journal of orthopaedic translation·2026
Same author

Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies.

Nature communications·2026
Same author

Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerability.

Biomaterials·2025
Same author

Sequence Permutation Generated Lysine and Tryptophan-Rich Antimicrobial Peptides with Enhanced Therapeutic Index.

Antibiotics (Basel, Switzerland)·2025

Related Experiment Video

Updated: Apr 12, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.6K

Novel antimicrobial peptides with high anticancer activity and selectivity.

Hung-Lun Chu1, Bak-Sau Yip2, Kuan-Hao Chen1

  • 1Institute of Biotechnology and Department of Medical Science, National Tsing Hua University, Hsinchu, 300, Taiwan.

Plos One
|May 14, 2015
PubMed
Summary

Researchers enhanced antimicrobial peptides to create potent anticancer drugs. The modified peptide K4R2-Nal2-S1 shows reduced toxicity and effectively targets lung tumors, offering new therapeutic possibilities.

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.2K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

3.1K

Related Experiment Videos

Last Updated: Apr 12, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.6K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.2K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

3.1K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Short antimicrobial peptides (AMPs) show promise but require optimization for therapeutic use.
  • Enhancing AMPs can improve anticancer activity and reduce normal cell toxicity.
  • Modifications often involve altering amino acid composition and structure.

Purpose of the Study:

  • To develop a strategy for boosting the anticancer efficacy of AMPs.
  • To reduce the toxicity of AMPs towards normal cells, such as human red blood cells (hRBCs) and human fibroblasts.
  • To investigate the therapeutic potential of modified AMPs in preclinical cancer models.

Main Methods:

  • Designed novel peptides by incorporating positively charged amino acids and bulky non-natural amino acids (β-naphthylalanine) into AMP termini.
  • Evaluated salt resistance and cytotoxicity of designed peptides against hRBCs and human fibroblasts.
  • Utilized fluorescence microscopy to assess cellular binding and cell death mechanisms.
  • Tested the efficacy of the lead peptide in a human lung tumor xenograft mouse model.

Main Results:

  • The peptide K4R2-Nal2-S1 demonstrated superior salt resistance and lower toxicity compared to control peptides (Nal2-S1, K6-Nal2-S1).
  • FITC-labeled K4R2-Nal2-S1 showed preferential binding to cancer cells, inducing apoptotic cell death.
  • Significant inhibition of human lung tumor growth was observed in mice treated with K4R2-Nal2-S1.

Conclusions:

  • The strategy of adding positive charge and bulky non-natural amino acids effectively enhances AMP anticancer activity and selectivity.
  • K4R2-Nal2-S1 represents a promising candidate for developing targeted antimicrobial and anticancer peptide therapeutics.
  • This approach offers new avenues for creating safer and more effective peptide-based drugs.